U.S. market Closed. Opens in 6 hours 11 minutes

VRCA | Verrica Pharmaceuticals Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
Revenue5.12M9.03M12.00MN/AN/AN/AN/AN/A
Cost of Revenue1.16M725.00K472.00K229.00K257.20KN/AN/AN/A
Gross Profit3.96M8.31M11.53M-229.00K-257.20KN/AN/AN/A
Operating Expenses67.18M29.60M42.91M40.18M30.08M21.88M4.46MN/A
Selling, General & Admin46.89M17.41M26.98M24.51M14.64M9.05M727.00K204.00K
Research & Development20.30M12.20M15.93M15.67M15.44M12.83M3.73M1.71M
Other Operating Expenses-14.00K-58.00KN/A-1.00K1.87M-1.00KN/AN/A
Operating Income-63.22M-21.30M-30.91M-40.18M-30.08M-21.88M-4.46M-1.91M
Other Expenses / Income-3.77M-3.19M-4.17M-2.51M1.87M-1.00K-2.00KN/A
Before Tax Income-67.00M-24.49M-35.08M-42.69M-28.21M-20.65M-4.46M-1.91M
Income Tax Expenses668.11K3.19M3.82M2.80M-257.00K1.23MN/AN/A
Net Income-67.00M-27.68M-38.90M-45.50M-27.95M-20.65M-4.46M-1.91M
Interest Expenses3.96M2.17M4.29M3.03MN/AN/A2.00KN/A
Basic Shares Outstanding45.34M34.16M27.04M25.00M24.90M14.66M17.26M19.95M
Diluted Shares Outstanding45.34M34.16M27.04M25.00M24.90M14.66M17.26M19.95M
EBITDA-62.39M-20.88M-30.79M-39.66M-30.08M-20.65M-4.46M-1.91M
EBITDA Margin-1,217.53%-231.16%-256.54%0.00%0.00%0.00%0.00%0.00%
EBIT-62.36M-22.32M-30.79M-39.66M-28.21M-19.42M-4.46M-1.91M
EBIT Margin-1,217.11%-247.07%-256.54%0.00%0.00%0.00%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙